Loading
Dr. Suthan Chanthawong

Dr. Suthan Chanthawong

เภสัชกรรมคลินิก,
Faculty of Pharmaceutical Sciences,
Khon Kaen University
55014567400: H-INDEX 4

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Pharmacist’s Intervention on Managing Drug Related Problems in Easy Asthma Clinic, Srinagarind Hospital Sunee Lertsinudom
Watchara Boonsawat
Chanee Samosorn
Suthan Chanthawong
2008
2. Validity and reliability of the Thai Mini Asthma Quality of Life Questionnaire. Lertsinudom, S
Johns, NP
Chanthawong, S
Boonsawat, W
Samosorn, C
2010
3. Drug Use Review of Olanzapine for Psychiatric Outpatients at Srinagarind Hospital Suthan Chanthawong
Pattharee Paholpak
Samai Junnamom
Suphat Subongkot
Denpong Patthanasetthanon
Wilaiwan Boontawee
Amornrat Shoora
Suchat Paholpak
2012
4. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence Teo, Y.L.
Saetaew, M.
Chanthawong, S.
Ho, H.K.
2012
5. Liver enzymes elevation due to concurrent dexamethasone and lapatinib: Clinical and in vitro evidence Yi Ling Teo
Manit Saetaew
Suthan Chanthawong
Yoon Sim Yap
Eric Chun Yong Chan
Han Kiat Ho
Alexandre Chan
2012
6. Olanzapine induced weight gain in patients with cancer-related cachexia Suthan Chanthawong
Jarin Chindaprasirt
Tanarak Chaiyamee
Sawanit Suwannarat
2012
7. A Retrospective Study of Carboplatin Adverse Effects in Oncology Patient at Bumrungrad International Hospital from January 2011 to January 2012 Suthan Chanthawong
Surasit Issarachai
Nirachorn Kuchonthara
Awika Setrit
Nantanat Prempraphan
Suphansa Phalapanyakoon
2013
8. The application of telephone call back to survey the incidences of adverse drug events of ambulatory oncology patients Sirikarn Kawin-atichart
Preeyanuch Weeraprasit
Nantanat Prempraphan
Khon Kaen University Pharmaceutical sciences
Aumkhae Sookprasert
40002 Khon Kaen
Suthan Chanthawong
Khon Kaen University Faculty of Pharmaceutical sciences
2013
9. การประเมินความรู้ผู้ป่วยมะเร็งที่ได้รับการรักษาด้วยยาเคมีบำบัด ณ โรงพยาบาลอุดรธานี ปภาวี พิมพ์ทอง
เกษราภรณ์ เยาวะพันธ์
ชัยณรงค์ เบ้ารักษา
สุธาร จันทะวงศ์
2013
10. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting Chanthawong, S
Subongkot, S
Sookprasert, A
2014
11. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study Chanthawong, S
Lim, YH
Subongkot, S
Chan, A
Andalusia, R
Ahmad Bustamam, RS
Chaiyakunapruk, N
2019
12. An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study Yoodee, J
Sookprasert, A
Sanguanboonyaphong, P
Chanthawong, S
Seateaw, M
Subongkot, S
2021
13. Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients. Komvilaisak, P.
,
Chanthawong, S.
Subongkot, S.
2022
Count 4 6 4 6

Title Authors Year Publication name Cited count
< 2020 2021 2022 2023 2024 2025 Total
1. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: Clinical and in vitro evidence Teo, Y.L.
Saetaew, M.
Chanthawong, S.
Ho, H.K.
2012 Breast Cancer Research and Treatment
2 (133), pp. 703-711
2. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting Chanthawong, S.
Subongkot, S.
Sookprasert, A.
2014 Journal of the Medical Association of Thailand
3 (97), pp. 349-355
3. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study Chanthawong, S.
Subongkot, S.
Chaiyakunapruk, N.
2019 Supportive Care in Cancer
3 (27), pp. 1109-1119
4. Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients Komvilaisak, P.
,
Chanthawong, S.
Subongkot, S.
2022 Asian Pacific Journal of Cancer Prevention
1 (23), pp. 93-100

Title Authors Year Journal title
1. Validity and reliability of the Thai Mini Asthma Quality of Life Questionnaire. Lertsinudom, S
Johns, NP
Chanthawong, S
Boonsawat, W
Samosorn, C
2010 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
3 (93), pp. 373-7
2. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence. Teo, YL
Saetaew, M
Chanthawong, S
Yap, YS
Chan, EC
Ho, HK
Chan, A
2012 Breast cancer research and treatment
2 (133), pp. 703-11
3. Effectiveness of olanzapine for the treatment of breakthrough chemotherapy induced nausea and vomiting. Chanthawong, S
Subongkot, S
Sookprasert, A
2014 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
3 (97), pp. 349-55
4. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study. Chanthawong, S
Lim, YH
Subongkot, S
Chan, A
Andalusia, R
Ahmad Bustamam, RS
Chaiyakunapruk, N
2019 Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
3 (27), pp. 1109-1119
5. An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study. Yoodee, J
Sookprasert, A
Sanguanboonyaphong, P
Chanthawong, S
Seateaw, M
Subongkot, S
2021 Clinics and practice
3 (11), pp. 484-493
6. Predictors of Chemotherapy Induced Adverse Events in Pediatric Osteosarcoma Patients. Sanguanboonyaphong, P
Komvilaisak, P
Suwannaying, K
Yoodee, J
Saeteaw, M
Chanthawong, S
Subongkot, S
2022 Asian Pacific journal of cancer prevention : APJCP
1 (23), pp. 93-100

Title Authors Year Journal title Cited count
< 2020 2021 2022 2023 2024 2025 Total
1. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence Yi Ling Teo
Manit Saetaew
Suthan Chanthawong
Yoon Sim Yap
Eric Chun Yong Chan
Han Kiat Ho
Alexandre Chan
2012 BREAST CANCER RESEARCH AND TREATMENT
2.0 (133.0), pp. 703.0-711.0
47 0 0 0 0 0 47
2. Liver enzymes elevation due to concurrent dexamethasone and lapatinib: Clinical and in vitro evidence Yi Ling Teo
Manit Saetaew
Suthan Chanthawong
Yoon Sim Yap
Eric Chun Yong Chan
Han Kiat Ho
Alexandre Chan
2012 JOURNAL OF CLINICAL ONCOLOGY
15.0 (30.0), pp.
0 0 0 0 0 0 0
3. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for managing highly emetogenic chemotherapy in Southeast Asia: a multinational study Suthan Chanthawong
Yi Heng Lim
Suphat Subongkot
Alexandre Chan
Rizka Andalusia
Ros Suzanna Ahmad Bustamam
Nathorn Chaiyakunapruk
2019 SUPPORTIVE CARE IN CANCER
3.0 (27.0), pp. 1109.0-1119.0
19 0 0 0 0 0 19
4. An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study Jukapun Yoodee
Aumkhae Sookprasert
Phitjira Sanguanboonyaphong
Suthan Chanthawong
Manit Seateaw
Suphat Subongkot
2021 CLINICS AND PRACTICE
3.0 (11.0), pp. 484.0-493.0
0 0 0 0 0 0 0

Title Authors Year Journal title
1. Pharmacist’s Intervention on Managing Drug Related Problems in Easy Asthma Clinic, Srinagarind Hospital Sunee Lertsinudom
Watchara Boonsawat
Chanee Samosorn
Suthan Chanthawong
2008 Isan Journal of Pharmaceutical Sciences
(4 No 2), pp. 13-23
2. Olanzapine induced weight gain in patients with cancer-related cachexia Suthan Chanthawong
Jarin Chindaprasirt
Tanarak Chaiyamee
Sawanit Suwannarat
2012 Isan Journal of Pharmaceutical Sciences
(8 No 3), pp. 1-9
3. Drug Use Review of Olanzapine for Psychiatric Outpatients at Srinagarind Hospital Suthan Chanthawong
Pattharee Paholpak
Samai Junnamom
Suphat Subongkot
Denpong Patthanasetthanon
Wilaiwan Boontawee
Amornrat Shoora
Suchat Paholpak
2012 Journal of the Psychiatric Association of Thailand
(57 No 4), pp. 447-454
4. A Retrospective Study of Carboplatin Adverse Effects in Oncology Patient at Bumrungrad International Hospital from January 2011 to January 2012 Suthan Chanthawong
Surasit Issarachai
Nirachorn Kuchonthara
Awika Setrit
Nantanat Prempraphan
Suphansa Phalapanyakoon
2013 Isan Journal of Pharmaceutical Sciences
(9 No 1), pp. 31
5. The application of telephone call back to survey the incidences of adverse drug events of ambulatory oncology patients Sirikarn Kawin-atichart
Preeyanuch Weeraprasit
Nantanat Prempraphan
Khon Kaen University Pharmaceutical sciences
Aumkhae Sookprasert
40002 Khon Kaen
Suthan Chanthawong
Khon Kaen University Faculty of Pharmaceutical sciences
2013 Isan Journal of Pharmaceutical Sciences
(9 No 1), pp. 30
6. การประเมินความรู้ผู้ป่วยมะเร็งที่ได้รับการรักษาด้วยยาเคมีบำบัด ณ โรงพยาบาลอุดรธานี ปภาวี พิมพ์ทอง
เกษราภรณ์ เยาวะพันธ์
ชัยณรงค์ เบ้ารักษา
สุธาร จันทะวงศ์
2013 Isan Journal of Pharmaceutical Sciences
(9 No 1), pp. 30

Title Authors NRIIS type Year NRIIS Scholarship

0.013327836990356445